Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1988-04-21
1990-10-09
Friedman, Sidney J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 3140
Patent
active
049621211
ABSTRACT:
A method and composition is described for treating neurological diseases such as migraine, by influencing the nerve cells. This is achieved by optimizing the ability of the nerve cell gliacytes to transport taurine and the ability of the nerve cells to absorb taurine, by the external supply of amino acids occurring normally in the body. Preferred compositions include taurine, L-carnitine, zinc gluconate and calcium glycerophosphate.
REFERENCES:
patent: 4303692 (1981-12-01), Gaull
patent: 4434160 (1984-02-01), Jeretin et al.
patent: 4439452 (1984-03-01), Ehrenpreis et al.
patent: 4629625 (1986-12-01), Gaull
patent: 4687782 (1987-08-01), Brantman
patent: 4725427 (1988-02-01), Ashmead et al.
patent: 4753926 (1988-06-01), Lucas et al.
Tomichek et al., "Role of Vitamines in Taurine Synthesis from Sulfate by the Chick," J. Nutr. 102: 313-318 (1972).
Bland, Octacosanol, Cornitine, and other Accessory Nutrients, pp. 4-13 (1982).
Duke, S. F., The Chemistry of the Vitamins, p. 75 (1965).
Hamberger Anders
Van Gelder Nico M.
LandOfFree
Method and composition for treating neurological diseases such a does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method and composition for treating neurological diseases such a, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and composition for treating neurological diseases such a will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-973810